(ii) Reduction of surgical site recurrence risk: curcumin exhibits anti-tumor activity by modulating the NF-κB and PI3K/AKT mitogen-activated protein kinase pathways, thereby inhibiting tumor cell proliferation and metastatic potential. This evidence concerns the gene WNK2 and neoplasm.